Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Edwards Lifesciences Corporation (EW)
Market Closed
1 Sep, 20:00
NYSE
All
(9)
DE
(5)
AT
(1)
IT
(1)
MX
(1)
US
(1)
XMEX
Primary
XDUS
XWBO
NYSE
XFRA
XMUN
XETRA
XMIL
XSTU
$
90.
74
-0.01
-0.011%
After Hours
$
91.
69
+0.95
+1.0469%
48.42B
Market Cap
32.12
P/E Ratio
-
Div Yield
2.54M
Volume
2.51
Eps
$
90.75
Previous Close
Investors:
TJD
DI
LC
BZ
+310
Watching
Watch
Add Transaction
Day Range
90.1
92.95
Year Range
72.3
96.29
Want to track
EW
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Earnings
Splits
Statistics
Historical Data
Investors
Edwards Lifesciences Corporation (EW) Statistics
Valuation metrics
Market Cap
48.42B
Enterprise value
49.74B
Trailing P/E (ttm)
51.84
Forward P/E
24.74
PEG ratio
-0.69
Price/Sales (ttm)
7.98
Price/Book (mrq)
4.9
Enterprise Value/Revenue
7.64
Enterprise Value/EBITDA
32.3
Overview
Shares outstanding
580.7M
Float
579.03M
Shares short
12.38M
% Held by insiders
0.01%
% Held by institutions
0.92%
Average volume (10 days)
2.75M
Average volume (90 days)
4.1M
Price summary
52-Week low
72.3
52-Week high
96.29
Beta
0.93
50-Day moving average
89.07
200-Day moving average
83.44
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
-
Trailing annual dividend yield
-
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
-
Ex-Dividend Date
-
Last split factor
3:1
Last split Date
1 Jun 2020
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.15%
Operating margin
0.28%
Operational effectiveness
Return on assets
0.07%
Return on equity
0.1%
Income Statement
Revenue (ttm)
6.07B
Revenue per share (ttm)
11.3
Quarterly revenue growth (yoy)
0.13%
Gross profit (ttm)
4.73B
EBITDA
1.96B
Net income to common (ttm)
1.06B
Diluted EPS (ttm)
1.74
Quarterly earnings growth (yoy)
-0.76%
Balance Sheet
Total cash (mrq)
4.23B
Total cash per share (mrq)
7.38
Total debt (mrq)
705.4M
Total Debt/Equity (mrq)
0.07
Current ratio (mrq)
4.52%
Book value per share (mrq)
18.61
Cash Flow
Cash flow statement
1.6B
Levered free cash flow (LFCF)
1.17B